UPDATE: HR 2239 did not pass in the 112th Congress. In February 2013, the Act was reintroduced in the 113th Congress as HR 842. Please see the March 2, 2013 post or click on the HR 842 category on the blog sidebar for updated information.
According to THOMAS, the Library of Congress legislative database, as of several days ago, Representative Elton Gallegly (R-CA-24) is a co-sponsor to HR 2239, the Functional Gastrointestinal and Motility Disorders Research Enhancement Act of 2011. He joins the lead sponsor, Representative F. James Sensenbrenner, Jr. (R-WI-5) and co-sponsors, Representative James Moran (D-VA-8) and Representative Peter Welch (D-VT) in supporting HR 2239.
The 24th Congressional District of California covers parts of Ventura and Santa Barbara Counties. If you are a U.S. citizen who lives within its boundaries, please write or call Representative Gallegly to thank him for his support of the IBS and FGIMD community.
If you are a constituent of Representative Sensenbrenner, residing in Wisconsin’s 5th Congressional District, or a constituent of Representative Moran, residing in Virginia’s 8th Congressional District, or a constituent of Representative Welch, who is the at-large Member of Congress for the entire state of Vermont, please do the same with your respective Representative.
If your Member of Congress is not yet a co-sponsor of HR 2239 and you have not contacted him or her recently to ask for his or her support, please see this previous post from July 6 for links to the bill and more details on how to do so. Often, it takes multiple attempts to elicit any interest from legislators, so if you do not receive a response within a few months of your inquiry, periodically try again.
According to the information on THOMAS, it appears that the bill is currently under consideration in the Subcommittee on Health. If you would like to see a list of the members of that Subcommittee, click here and scroll down to the fourth subcommittee listing.
Check back on this blog or join IBS Impact’s Yahoo discussion group for further updates on HR 2239 as they occur.